This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree
"Target grants aimed at solving the problems caused by the SARS-CoV-2 virus" project COVSG9
COVSG9 "Polymer nanocomposites applied to anti-viral additives and antiviral coatings for surfaces protection (1.11.2020−31.12.2021)", Erwan Yann Rauwel, Estonian University of Life Sciences.
COVSG9
Polümeersete nanokomposiitide kasutamine anti-viraalsetes lisandites ja pinnakatetes
Polymer nanocomposites applied to anti-viral additives and antiviral coatings for surfaces protection
1.11.2020
31.12.2021
R&D project
Target grants aimed at solving the problems caused by the SARS-CoV-2 virus
ETIS classificationSubfieldCERCS classificationFrascati Manual classificationPercent
1. Biosciences and Environment1.2. MicrobiologyB230 Microbiology, bacteriology, virology, mycology 1.6 Biological sciences50,0
4. Natural Sciences and Engineering4.11. Chemistry and Chemical TechnologyT390 Polymer technology, biopolymers 1.4 Chemical sciences20,0
4. Natural Sciences and Engineering4.12. Process Technology and Materials ScienceT152 Composite materials 2.10 Nano-technology30,0
InstitutionRolePeriod
Estonian University of Life Sciencescoordinaator01.12.2020−31.12.2021
PeriodSum
01.11.2020−31.12.2021100 000,00 EUR
100 000,00 EUR

COVID-19 puhang nõuab koheselt efektiivseid antiviraalseid lisandeid ja pinnakattevahendeid et selle levikut tõkestada. Alates 2004 aastast on uuritud nanomaterjale mis on ilmutanud antimikroobseid omadusi. COVID-19 pandeemiaga on esile kerkinud nanomaterjalide antiviraalsed omadused. Antiviraalses nanomaterjalide kasutuses lubavad metallidega impregneeritud nanokomposiidid kujundada saastus-kindlat tehnikat ja varustust. Projektis uuritakse koobaltit, vaske ja hõbeda nanoosakesi sisaldavaid polümeermaatrikseid, et välja töötada antiviraalseid lisandeid plastikute ja pinnakatete tootmiseks (uksekäepidemed, kaitsevisiirid, paneelid jms). Tehnoloogiasiire viiakse läbi Eesti ettevõtetes. Erinevate nanostruktuuride antiviraalseid omadusi uuritakse ja kasutatakse COVID-19 võitlemiseks ja selle leviku ennetamiseks.
The COVID-19 outbreak requires urgent effective antiviral treatment as well as mitigation of its proliferation. Since 2004, nanomaterials have been investigated towards the development of the so-called ‘nanoantimicrobials,’. Now with COVID-19 pandemic, nanoantivirals have been the focus of investigations. Nanomaterials in antiviral applications and nanotechnology can offer a great support in the design of contamination-safe equipment through metal-loaded nanocomposites. Polymer nanocomposites combining cobalt, copper and silver in polymer matrix will be studied to develop antiviral additives for plastic items production and coatings to protect surfaces (door handles, protective visors, panels…). The technological transfer for industrial production will be done with Estonian Companies. The well-known antiviral properties of various formulations and nanostructures will be studied and exploited to fight COVID-19 and prevent and limit both rapid contamination leading to contagion.